Medtech startup See-Mode gets Canada's nod for AI breast, thyroid ultrasound analysis software
Its technology helps eliminate manual steps in reporting and interpretation of ultrasound images of breast and thyroid.
Stay updated with breaking news from Augmented Vascular Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Its technology helps eliminate manual steps in reporting and interpretation of ultrasound images of breast and thyroid.
(1) SINGAPORE and MELBOURNE, Australia, Feb. 2, 2021 /PRNewswire/ -- See-Mode Technologies, a MedTech startup based in Singapore and Australia that seeks to empower clinicians to better predict stroke, today announced that it has received two more regulatory approvals - the CE Mark and Therapeutic Goods Administration (TGA) approval for its debut product, the Augmented Vascular Analysis (AVA) software. AVA uses Artificial Intelligence (AI) to perform automated analysis and reporting of vascular ultrasound scans, enabling clinicians to interpret and report on these scans more efficiently and ...